Associate Professor of Medicine

Associate Professor of Medicine
Clinical Pharmacology

Professional Bio

Julie Sterling A. Rhodes, PhD, is an Associate Professor of Medicine in the Division of Clinical Pharmacology within the Department of Medicine at Vanderbilt University Medical Center.

Dr. Sterling graduated from the Medical College of Ohio (now the University of Toledo Medical Branch), where she studied the transcriptional regulation of TGF-β Receptor Type II during breast cancer progression in the laboratory of Sunandita (Sheila) Banerji.  During this time she developed an interest in TGF-β signaling regulation of metastasis, with a specific interest in bone metastases. This interest led her to a post-doctoral fellowship with Dr. Gregory R. Mundy at the University of Texas Health Science Center in San Antonio where she began working on PTHrP regulation in bone metastases. In 2006 she moved to Vanderbilt with Dr. Mundy where she continued her work in bone metastases and developed her independent research.  

Dr. Sterling's laboratory currently focuses on the complex interactions between tumors and the bone micro-environment. To do this, the Sterling lab uses multi-discipline approaches that incorporate molecular biology, pre-clinical models, imaging, and engineering.


PhD - Molecular and Cellular Biology - University of toledo - 2003
Fellowship - Cellular and Structural Biology - University of Toledo - 2006
Fellowship - Clinical Pharmacology - Vanderbilt University - 2008